$IBB Headlines Charting the S&P 500’s slow-motion

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 1:02 PM

$IBB Headlines

Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 10:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 9:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 9:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 3:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 5:01 a.m. Sept. 7, 2014 - Wallace Witkowski
S&P clears the 2,000 mark, reaches uncharted territory 10:49 a.m. Aug. 26, 2014 - Michael Ashbaugh
S&P clears the 2,000 mark, reaches uncharted territory 10:35 a.m. Aug. 26, 2014 - Michael Ashbaugh
This one stock sector can withstand all the ‘bubble’ talk 5:01 a.m. Aug. 21, 2014 - Jeff Reeves
S&P 500 retests the breakdown point 10:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Dow, S&P 500 inch up, while Nasdaq, Russell 2000 slip: stock market live blog recap 2:34 p.m. July 28, 2014 - blogs.marketwatch.com
Momentum plays stabilize: Biotech, social-media stocks rally in the past week 4:52 p.m. July 25, 2014 - blogs.marketwatch.com

Biotech Ripe for Correction as Risk of Cyclical Drawdown Looms 3:15 p.m. Nov. 10, 2014 - TheStreet.com
FibroGen on deck for IPO 1:46 p.m. Nov. 10, 2014 - Seeking Alpha
Stocks Inch to New Records, But Who the Heck Is Buying? 11:25 a.m. Nov. 10, 2014 - InvestorPlace.com
Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection 10:28 a.m. Nov. 10, 2014 - Seeking Alpha
Market Due for a Pullback, but How Deep? 8:31 p.m. Nov. 9, 2014 - InvestorPlace.com
Jaguar Animal Health postpones IPO 11:57 a.m. Nov. 7, 2014 - Seeking Alpha
Joint Corporation on deck for IPO 11:46 a.m. Nov. 7, 2014 - Seeking Alpha
Nevro debuts strongly 11:03 a.m. Nov. 7, 2014 - Seeking Alpha
Coherus Bio stumbles in debut 1:59 p.m. Nov. 6, 2014 - Seeking Alpha
Post-Election Action Puts Near-Term Trend in Doubt 8:27 p.m. Nov. 5, 2014 - InvestorPlace.com
INC Research on deck for IPO 1:42 p.m. Nov. 5, 2014 - Seeking Alpha
Xenon Pharma up modestly in debut 1:12 p.m. Nov. 5, 2014 - Seeking Alpha
Vote Cannabis? Marijuana Gains Political Traction on the Ballot 5:04 p.m. Nov. 4, 2014 - TheStreet.com
Stocks Surge as Japan Joins Stimulus Party 9:39 p.m. Nov. 2, 2014 - InvestorPlace.com
Don't Fight The Fed? 12:28 p.m. Oct. 27, 2014 - Seeking Alpha
New Highs May Not Happen Till Mid-November 9:01 p.m. Oct. 26, 2014 - InvestorPlace.com
Biotechs are running circles around internet stocks 9:44 a.m. Oct. 26, 2014 - Seeking Alpha
Best And Worst ETFs Of The Week Amid Biotech Breakout 3:41 p.m. Oct. 24, 2014 - Benzinga.com
Biotech Breakout: Technical Analysis And Major News 8:49 a.m. Oct. 24, 2014 - Seeking Alpha
Are Blue-Chip Stocks Past Their Prime or Still Worth Owning? 4:15 p.m. Oct. 23, 2014 - TheStreet.com

Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 11:06 a.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 8:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 8:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 7:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 7:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 7:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 7:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 7:52 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FOTON Accelerates Global Push with European Focus

The Road to Global Dominance Ever feel like someone’s racing past you while others try to catch up? That’s FOTON in the relentless world of commercial vehicles. This juggernaut of a company isn't just satisfied with leading the pack; they’ve got their eyes set on redefines the game, especially with their new moves in Europe. A Shift in Strategy Right now, the...

KuCoin's KCUSD Tackles Stablecoin Idle Capital Problem

KuCoin's Bold Move with KCUSD Folks, the cat's outta the bag with KuCoin's latest maneuver—introducing KCUSD. At first glance, it seems like they're just introducing another fancy stablecoin product, but peel the onion and there's more to it. We're talking about shaking up how stablecoins sit tight doing nada in the crypto world. KCUSD is out to make those idle balances...

TECNO CAMON Slim 5G: Where Art Meets Tech

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Huion Kamvas Pad 12: A Creative Power Tool

The Kamvas Pad 12 Hits the Market In a crowded tablet market that's fierce with innovation, Huion tossed their latest tool into the ring—the Kamvas Pad 12. Now, anyone who’s been watching the digital art scene won't be surprised that Huion, with its decade and a half of digital prowess, is pulling another tablet trick out of its hat. Key Features and Innovations If...

Summit Tackles BRI Infrastructure's Role in Global SDGs

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Clover's RSV Combo Vaccine Shows Promise in Trials

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Europe's Largest Carbon Capture Facility Launches

A New Chapter in Industrial Decarbonization Today's not just your average ribbon-cutting ceremony; it's a landmark turn in our journey toward a cleaner Europe. Yara's Sluiskil plant in the Netherlands just fired up Europe's biggest carbon capture facility, marking a crucial pivot point in industrial decarbonization. We're talking about capturing a staggering 800,000 tons...

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

AION UT Sets New Safety Standard in Euro NCAP 2026

The New Gold Standard in Safety for Small EVs Hop into your favorite auto forum and you'll hear more than a buzz—it's a full-blown ruckus. The reason? GAC’s AION UT just nabbed a 2026 Euro NCAP Five-Star Safety Rating. Now, this isn’t just another accolade in a crowded trophy room; it’s a statement, a seismic shift in how small electric vehicles stack up in terms...

Ping An Climbs Sustainability Ladder, Scores A+ Rating

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...